De-risking primary and secondary pharmacology mediated adverse effects as a path to increase likelihood of success in drug development. (20th October 2017)

Record Type:: Journal Article
Title:: De-risking primary and secondary pharmacology mediated adverse effects as a path to increase likelihood of success in drug development. (20th October 2017)
Main Title:: De-risking primary and secondary pharmacology mediated adverse effects as a path to increase likelihood of success in drug development
Authors:: Valentin, Jean-Pierre
Atienzar, Franck
Class, Reiner
Delaunois, Annie
Fleurance, Renaud
Gerets, Helga
Glineur, Stéphanie
Gryshkova, Vitalina
Hall, Peter
Hasselgren, Catrin
Tilmant, Karen
Abstract:
Is Part Of:: Toxicology letters. Volume 280(2017)Supplement 1
Journal:: Toxicology letters
Issue:: Volume 280(2017)Supplement 1
Issue Display:: Volume 280, Issue 1 (2017)
Year:: 2017
Volume:: 280
Issue:: 1
Issue Sort Value:: 2017-0280-0001-0000
Page Start:: S77
Page End:
Publication Date:: 2017-10-20
Subjects:: Toxicology -- Periodicals
363.179
Journal URLs:: http://www.sciencedirect.com/science/journal/03784274 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.toxlet.2017.07.202 ↗
Languages:: English
ISSNs:: 0378-4274
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8873.042000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 8565.xml